484 related articles for article (PubMed ID: 17224854)
1. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
[TBL] [Abstract][Full Text] [Related]
2. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
[TBL] [Abstract][Full Text] [Related]
3. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
4. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
[TBL] [Abstract][Full Text] [Related]
5. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
6. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
Noyan V; Yucel A; Sagsoz N
Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
[TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.
Maturana MA; Moreira RM; Spritzer PM
Maturitas; 2011 Dec; 70(4):395-9. PubMed ID: 22018728
[TBL] [Abstract][Full Text] [Related]
8. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
Worsley R; Robinson PJ; Bell RJ; Moufarege A; Davis SR
Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
[TBL] [Abstract][Full Text] [Related]
9. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
10. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.
Khatibi A; Agardh CD; Shakir YA; Nerbrand C; Nyberg P; Lidfeldt J; Samsioe G
Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141
[TBL] [Abstract][Full Text] [Related]
11. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
Maturana MA; Breda V; Lhullier F; Spritzer PM
Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
[TBL] [Abstract][Full Text] [Related]
12. Lipid profile of women with premature ovarian failure.
Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
14. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
[TBL] [Abstract][Full Text] [Related]
16. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
Davis SR; Robinson PJ; Moufarege A; Bell RJ
Clin Endocrinol (Oxf); 2012 Oct; 77(4):541-7. PubMed ID: 22106826
[TBL] [Abstract][Full Text] [Related]
17. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ
Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone-binding globulin and lipid profile in pubertal children.
Garcés C; Oya Id; Lasunción MA; López-Simón L; Cano B; de Oya M
Metabolism; 2010 Feb; 59(2):166-71. PubMed ID: 19765778
[TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
20. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study.
Vaziri SM; Evans JC; Larson MG; Wilson PW
Arch Intern Med; 1993 Oct; 153(19):2200-6. PubMed ID: 8215723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
